Can we overcome the heterogeneity of mood disorders in clinical trials?
Author:
Affiliation:
1. Orygen, Parkville, VIC, Australia
2. Centre for Youth Mental Health, The University of Melbourne, Parkville, VIC, Australia
3. IMPACT, Deakin University, Parkville, VIC, Australia
Publisher
SAGE Publications
Subject
Psychiatry and Mental health,General Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/00048674231158266
Reference5 articles.
1. The heterogeneity of “major depression”
2. Are we failing clinical trials? A case for strong aggregate outcomes
3. Efficacy of Adjunctive Infliximab vs Placebo in the Treatment of Adults With Bipolar I/II Depression
4. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols
5. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prior psychiatric morbidity and differential psychopharmacological treatment patterns: Exploring the heterogeneity of bipolar disorder in a nationwide study of 9594 patients;Bipolar Disorders;2024-04-22
2. Editorial: Machine learning and big data analytics in mood disorders;Frontiers in Psychiatry;2024-04-17
3. Existential depression: A meaningful diagnostic entity?;Australasian Psychiatry;2023-06-08
4. Letter to the Editor regarding ‘Can we overcome the heterogeneity of mood disorders in clinical trials?’;Australian & New Zealand Journal of Psychiatry;2023-05-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3